Search - tctmd.com

Displaying 221 - 240 of 357

Sort: Relevancy | Date

Presentation TCT 2018

#6 The Russian Doll Approach Severe AS/AR With Bioprosthetic Valve Failure and Complex Anatomy - Case Presentation

Presenter: Amisha Patel

September 22, 2018

Presentation TCT 2018

Case #4: Bioprosthetic Valve Fracture - Before or After TAVR ViV?

Presenter: Massimo Napodano, Bernard Prendergast, Mohamed Abdel-Wahab, Robert J. Applegate, Vinayak Bapat, Alaide Chieffo, Jan Kovac, Juan A. Terré

September 22, 2018

Presentation TCT 2018

Case #3: A Case of Bioprosthetic Valve Fracture To Facilitate TAVR ViV

Presenter: Massimo Napodano, Bernard Prendergast, Mohamed Abdel-Wahab, Robert J. Applegate, Vinayak Bapat, Alaide Chieffo, Jan Kovac, Juan A. Terré

September 22, 2018

Presentation TCT 2018

Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends

Presenter: Michael J. Mack, Bernard Prendergast, George D. Dangas

September 22, 2018

Presentation TCT 2018

New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability

Presenter: Michael J. Mack, Bernard Prendergast, Davide Capodanno

September 22, 2018

Presentation TCT 2018

The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies

Presenter: Michael J. Mack, Bernard Prendergast, Lars Sondergaard

September 22, 2018

Presentation TCT 2018

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

Presenter: Michael J. Mack, Bernard Prendergast, Adam B. Greenbaum

September 22, 2018

Presentation TCT 2018

To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures

Presenter: Michael J. Mack, Bernard Prendergast, Adnan K. Chhatriwalla

September 22, 2018

Presentation TCT 2018

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

Presenter: Michael J. Mack, Bernard Prendergast, Philipp Blanke

September 22, 2018

Presentation TCT 2018

Clinical Lessons from the Global Aortic VIVID Registry Optimizing Procedural Outcomes

Presenter: Michael J. Mack, Bernard Prendergast, John G. Webb

September 22, 2018

Presentation TCT 2018

Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction During Transcatheter Aortic Valve Replacement: A Prospective IDE Trial (BASILICA)

Presenter: Jaffar M Khan

September 21, 2018

Presentation

Hemodynamic Deterioration of Surgically Implanted Bioprosthetic Aortic Valves

July 11, 2018

Presentation The Structural Heart Disease Summit 2018

Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends

Presenter: Michael J. Mack, Raj Makkar

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability

Presenter: Michael J. Mack, Raj Makkar, Maria Alu, MS

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies

Presenter: Michael J. Mack, Raj Makkar, Lars Sondergaard

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Percutaneous VA ECMO Supported Transcatheter Valve-in-Valve Implantation for Severe Bioprosthetic Pulmonic Valve Dysfunction Using Moderate Sedation in the Cardiac Catheterization Laboratory

Presenter: Isaac George, Christopher U. Meduri, Gautam Visveswaran, MD

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

New Standards for SAVR and TAVR Bioprosthetic Valve Dysfunction and Failure: A Consensus Statement from EAPCI, ESC, and EACTS

Presenter: Michael J. Mack, Bernard Prendergast

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

Presenter: Vinayak Bapat, Ran Kornowski, Adam B. Greenbaum

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures

Presenter: Vinayak Bapat, Ran Kornowski, Adnan K. Chhatriwalla

June 21, 2018

TCT 8: Aortic Paravalvular Amplatzer Plug Extractions, Valve in Valve TAVR and Intentional Bioprosthetic Valve Fracture: Percutaneous Aortic Annular Reconstruction to Eliminate Large Paravalvular Gaps With Severe Leak and Achieve Competence

Presentation The Structural Heart Disease Summit 2018

Aortic Paravalvular Amplatzer Plug Extractions, Valve-in-Valve TAVR, and Intentional Bioprosthetic Valve Fracture: Percutaneous Aortic Annular Reconstruction to Eliminate Large Paravalvular Gaps With Severe Leak and Achieve Competence

Presenter: Ashish Pershad, Mehul Patel

June 21, 2018

Advertisement

#6 The Russian Doll Approach Severe AS/AR With Bioprosthetic Valve Failure and Complex Anatomy - Case Presentation

Case #4: Bioprosthetic Valve Fracture - Before or After TAVR ViV?

Case #3: A Case of Bioprosthetic Valve Fracture To Facilitate TAVR ViV

Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends

New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability

The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

Clinical Lessons from the Global Aortic VIVID Registry Optimizing Procedural Outcomes

Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction During Transcatheter Aortic Valve Replacement: A Prospective IDE Trial (BASILICA)

Hemodynamic Deterioration of Surgically Implanted Bioprosthetic Aortic Valves

Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends

New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability

The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies

Percutaneous VA ECMO Supported Transcatheter Valve-in-Valve Implantation for Severe Bioprosthetic Pulmonic Valve Dysfunction Using Moderate Sedation in the Cardiac Catheterization Laboratory

New Standards for SAVR and TAVR Bioprosthetic Valve Dysfunction and Failure: A Consensus Statement from EAPCI, ESC, and EACTS

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures

Aortic Paravalvular Amplatzer Plug Extractions, Valve-in-Valve TAVR, and Intentional Bioprosthetic Valve Fracture: Percutaneous Aortic Annular Reconstruction to Eliminate Large Paravalvular Gaps With Severe Leak and Achieve Competence

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content